SurModics, Inc. announced it has acquired NorMedix, Inc. Gregg Sutton, current president and chief executive officer of NorMedix, will join the SurModics leadership team as vice president of R&D, reporting to Gary Maharaj.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.06 USD | -0.11% |
|
-0.14% | +15.65% |
07-01 | Surmodics, Inc.(NasdaqGS:SRDX) added to Russell Small Cap Comp Value Index | CI |
07-01 | Surmodics, Inc.(NasdaqGS:SRDX) added to Russell 2000 Defensive Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.65% | 601M | |
-4.41% | 179B | |
-1.68% | 100B | |
-6.99% | 46.16B | |
+18.16% | 44.81B | |
+9.65% | 44.38B | |
+13.68% | 29.53B | |
+22.31% | 25.83B | |
-7.13% | 23.97B | |
+3.73% | 22.5B |
- Stock Market
- Equities
- SRDX Stock
- News Surmodics, Inc.
- Surmodics, Inc. Appoints Gregg Sutton as Vice President of R&D